Prosight Management »

BioCryst Pharmaceuticals shares owned by Prosight Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Prosight Management from 13F filings

Historical chart of Prosight Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Prosight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Prosight Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.1M 1.4M 5.08
2023-09-30 $17M 2.4M 7.08
2023-06-30 $18M 2.5M 7.04
2023-03-31 $9.0M 1.1M 8.34
2022-12-31 $1.3M 117k 11.48
2022-09-30 $1.4M 114k 12.60
2022-06-30 $1.9M 177k 10.58